Recent News for ALPN - Alpine Immune Sciences, Inc.

Date Title
Apr 24 Have Insiders Been Buying Alpine Immune Sciences, Inc. (NASDAQ:ALPN) Shares?
Apr 18 Alpine Immune Sciences Appoints Stanford Peng to President and Head of Research and Development
Apr 11 The Zacks Analyst Blog Highlights: CMS Energy, Alpine Immune Sciences, Kohl's, Franklin Resources and Dominion Energy
Apr 10 5 Best Stocks to Buy Ahead of Q1 Earnings Season
Apr 5 Will Nivalis Therapeutics Continue to Surge Higher?
Apr 4 The Zacks Analyst Blog Highlights: Alpine, Actinium, Molecular Templates, Tricida and Otonomy
Apr 3 Small Drugmakers Outperforming the Bigshots: 7 Stocks to Buy
Mar 18 Alpine Immune Sciences misses by $0.01, misses on revenue
Mar 18 Alpine Immune Sciences Provides Corporate Update and Reports Full Year 2018 Financial Results
Mar 15 Top Ranked Momentum Stocks to Buy for March 15th
Mar 12 Alpine Immune Sciences (ALPN) Presents At Cowen And Company 39th Annual Health Care Conference - Slideshow
Mar 8 Alpine Immune Sciences: A New Name On The Radar
Mar 7 Diving Into Biotech With BioSci Capital Partners (Podcast)
Feb 19 Alpine Immune Sciences Presents Preclinical ALPN-101 GvHD Data at the 2019 Transplantation & Cellular Therapy Meetings of ASBMT and CIBMTR (TCT Meetings)
Feb 11 Alpine Immune Sciences Announces First Subjects Dosed in Phase I Clinical Trial for Lead Autoimmune/Inflammatory Disease Program ALPN-101
Jan 23 Microcaps mostly among midday movers
Jan 23 Microbot Medical leads healthcare gainers; Rexahn Pharmaceuticals tops the losers
Jan 23 Alpine Immune Sciences Inc (ALPN) Executive Chairman and CEO Mitchell Gold Bought $1 million of ...
Jan 16 Alpine Immune raises $25M via private placement
Jan 16 Alpine Immune Sciences Announces $25 Million Private Placement
Jan 4 Angion Completes Equity Financing and Appoints Senior Executives
Dec 28 The Daily Biotech Pulse: Opko Settles With SEC, Obalon Inks Financing Deals, Harpoon Files For IPO
Dec 27 The Daily Biotech Pulse: Tracon Aces Early-Stage Trials, Boston Scientific To Buy Out Millipede
Dec 26 55 Biggest Movers From Monday
Dec 24 Savara and CRISPR Therapeutics among healthcare gainers; EyePoint Pharmaceuticals and Novus Therapeutics among losers

Back to the Main ALPN Page...